StockNews.com downgraded shares of Relx (NYSE:RELX – Free Report) from a buy rating to a hold rating in a research note released on Saturday.
Separately, Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They issued a “buy” rating on the stock.
Get Our Latest Stock Report on RELX
Relx Price Performance
Relx Increases Dividend
The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. This is a boost from Relx’s previous semi-annual dividend of $0.23. Relx’s dividend payout ratio is currently 25.81%.
Hedge Funds Weigh In On Relx
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CENTRAL TRUST Co grew its position in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc purchased a new position in Relx during the 4th quarter worth approximately $31,000. Transce3nd LLC purchased a new position in Relx during the 4th quarter worth approximately $40,000. Sierra Ocean LLC purchased a new position in Relx during the 4th quarter worth approximately $43,000. Finally, Brown Brothers Harriman & Co. grew its position in Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after purchasing an additional 662 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- How to Calculate Return on Investment (ROI)
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- DuPont’s Electronics Spinoff: The Start of Something Big
- ETF Screener: Uses and Step-by-Step Guide
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.